Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia-Reference-Cited by-同舟云学术

Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia

Author:

Cressman Sonya¹²,Karsan Aly³⁴⁵,Hogge Donna E.⁶⁷⁸,McPherson Emily¹²,Bolbocean Corneliu¹²⁹,Regier Dean A.¹²⁹,Peacock Stuart J.¹²¹⁰

Affiliation:

1. Canadian Centre for Applied Research in Cancer Control (ARCC) Vancouver BC Canada

2. Department of Cancer Control BC Cancer Research Centre Vancouver BC Canada

3. Centre for Clinical Genomics Michael Smith Genome Sciences Centre Vancouver BC Canada

4. Cancer Genetics Laboratory British Columbia Cancer Agency Vancouver BC Canada

5. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

6. Terry Fox Laboratories British Columbia Cancer Research Centre Vancouver BC Canada

7. Leukemia Bone Marrow Transplant Program of BC Vancouver General Hospital Vancouver BC Canada

8. Department of Medicine University of British Columbia Vancouver BC Canada

9. School of Population and Public Health University of British Columbia Vancouver BC Canada

10. Faculty of Health Sciences Simon Fraser University Vancouver BC Canada

Funder

Genome British Columbia

Canadian Cancer Society

Publisher

Wiley

Subject

Hematology

Link

Reference39 articles.

5. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics;Caligiuri M.A.;Cancer Research,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献